Peter Matzneller
Impact in
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
- Pharmacology 26
- Antibiotics Pharmacokinetics and Efficacy 24
- Inflammatory mediators and NSAID effects 2
-
- Advancements in Transdermal Drug Delivery 3
- Co-authors
- Markus Alexander Zeitlinger (46 shared papers)Edith Lackner (15 shared papers)Markus Müller (4 shared papers)Oliver Langer (6 shared papers)Beatrix Wulkersdorfer (13 shared papers)Shaip Krasniqi (2 shared papers)F. Sörgel (2 shared papers)Martina Kinzig (2 shared papers)
In The Last Decade
Peter Matzneller
49 papers receiving 999 citations
Peers
Comparison fields: 5 of 86
- Pharmacology 286
- Molecular Medicine 78
- Oncology 185
- Microbiology 45
- Applied Microbiology and Biotechnology 14
Countries citing papers authored by Peter Matzneller
This map shows the geographic impact of Peter Matzneller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Matzneller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Matzneller more than expected).
Fields of papers citing papers by Peter Matzneller
This network shows the impact of papers produced by Peter Matzneller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Matzneller. The network helps show where Peter Matzneller may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Matzneller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 107 | |
| 2 | 2011 | 106 | |
| 3 | 2016 | 82 | |
| 4 | 2016 | 60 | |
| 5 | 2011 | 50 | |
| 6 | 2016 | 48 | |
| 7 | 2019 | 41 | |
| 8 | 2022 | 41 | |
| 9 | 2016 | 37 | |
| 10 | 2014 | 34 | |
| 11 | 2016 | 33 | |
| 12 | 2018 | 28 | |
| 13 | 2018 | 24 | |
| 14 | 2012 | 21 | |
| 15 | 2011 | 18 | |
| 16 | 2011 | 18 | |
| 17 | 2014 | 18 | |
| 18 | 2020 | 17 | |
| 19 | 2020 | 17 | |
| 20 | 2014 | 15 |
About Peter Matzneller
Peter Matzneller is a scholar working on Pharmacology, Pharmaceutical Science, Oncology, Infectious Diseases and Analytical Chemistry, having authored 53 papers that have together received 1k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (24 papers), Drug Transport and Resistance Mechanisms (5 papers), Sepsis Diagnosis and Treatment (4 papers), Analytical Methods in Pharmaceuticals (3 papers), Advancements in Transdermal Drug Delivery (3 papers), Inflammatory mediators and NSAID effects (2 papers), Antifungal resistance and susceptibility (2 papers) and Bacterial Identification and Susceptibility Testing (2 papers). The work is most often cited by research in Pharmacology (286 citations), Molecular Medicine (78 citations), Oncology (185 citations), Microbiology (45 citations) and Applied Microbiology and Biotechnology (14 citations). Peter Matzneller has collaborated with scholars based in Austria, Germany and Italy. Frequent co-authors include Markus Alexander Zeitlinger, Edith Lackner, Markus Müller, Oliver Langer, Beatrix Wulkersdorfer, Shaip Krasniqi, F. Sörgel, Martina Kinzig, S. Hüttner and Martin Bauer. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Clinical Pharmacokinetics, Frontiers in Medicine and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.